Skip to main content
Premium Trial:

Request an Annual Quote

Enigma Diagnostics Gets $3.3M Grant from UK Government

NEW YORK (GenomeWeb News) – Enigma Diagnostics has received a £1.8 million ($3.3 million) grant from the UK government’s Technology Strategy Board to help the firm develop its portable molecular diagnostics system.
The Porton Down, UK-based firm is developing a rapid, point-of-care system that will run DNA-based tests for infectious diseases. The funding will support its program to develop tests for sexually transmitted diseases, such as chlamydia, and healthcare-associated infections, such as methicillin-resistant Steprococcus aureus.
The company's portable, rapid, automated DNA analysis, or PRADA, system is based on proprietary technology, while real-time molecular assays for the instrument are being developed by researchers at the Centre for Healthcare Associated Infections at Nottingham University and Nottingham Trent University.
Privately held Enigma said that it holds an exclusive license to a portfolio of patents from the UK Ministry of Defence, as well as licenses from Applied Biosystems and Celera for the commercialization of real-time PCR instruments.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.